Alecmestencel-T (Apceth)

N/A

Report date: 2023/01/12 15:30:06

Base Information

Drug NameAlecmestencel-T (Apceth)

Drug Alias NameMSC_ApcethMSC Apceth

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionCell replacementsHematopoietic progenitor cell antigen CD34 modulators

TargetsHematopoietic progenitor cell antigen CD34

Therapy Area/IndicationsIschemiaPeripheral Arterial Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesApceth Gmbh & Co Kg

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesApceth Gmbh & Co Kg

Active IndicationsN/A

Inactive IndicationsIschemiaPeripheral Arterial Disease

Other Information

ATC CodeN/A